Skip to main content
. 2017 Aug 29;89(12):2207–2216. doi: 10.1002/jmv.24870

Figure 2.

Figure 2

(A) Tumor volumes represented as average per group (n = 5) of left (full circle) and right (open circle) tumors. In mice treated with GCb, GCb/VPA, and GCb/VPA/GCV tumor volumes decreased in time. Arrows represent administration of GCb, that is, 15 and 19 days after tumor inoculation. Numeric details of mean tumor volumes and standard deviations (SD) are presented in Supplemental Table S1. (B) EBV DNA load in circulation calculated as mean value plus SD (n = 5). Note the continued increase in untreated mice, while in VPA and GCV‐only treated mice a plateau was reached and high levels were measured. Combined/complete treatment reduced the EBV DNA load (starting from day 20) to virtually negative values at end of treatment, and the level in GCb‐only treated mice later raised again in time. Arrows represent administration of GCb, that is, 15 and 19 days after tumor inoculation. Upper bold line (purple) denotes timeframe of VPA administration and the line beneath (green) duration of GCV administration